Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening

[1]  X. Castells,et al.  Developing and validating an individualized breast cancer risk prediction model for women attending breast cancer screening , 2021, PloS one.

[2]  Tatiana Kelil,et al.  Post-lumpectomy breast calcifications: Can original tumor features assist in determining need for biopsy? , 2021, Clinical imaging.

[3]  X. Castells,et al.  Breast density, benign breast disease, and risk of breast cancer over time , 2021, European Radiology.

[4]  M. Sherman,et al.  Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-II , 2019, Breast Cancer Research and Treatment.

[5]  X. Castells,et al.  A systematic review and quality assessment of individualised breast cancer risk prediction models , 2019, British Journal of Cancer.

[6]  Lars J. Grimm,et al.  Growth Dynamics of Mammographic Calcifications: Differentiating Ductal Carcinoma in Situ from Benign Breast Disease. , 2019, Radiology.

[7]  Parijatham S. Thomas.  Diagnosis and Management of High-Risk Breast Lesions. , 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

[8]  A. Keshtkar,et al.  Subtypes of Benign Breast Disease as a Risk Factor of Breast Cancer: A Systematic Review and Meta Analyses , 2018, Iranian journal of medical sciences.

[9]  S. Heywang-Köbrunner,et al.  Use of single-view digital breast tomosynthesis (DBT) and ultrasound vs. additional views and ultrasound for the assessment of screen-detected abnormalities: German multi-reader study , 2018, Acta radiologica.

[10]  K. Czene,et al.  A clinical model for identifying the short-term risk of breast cancer , 2017, Breast Cancer Research.

[11]  S Gommers,et al.  Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study , 2016, European Radiology.

[12]  X. Castells,et al.  Risk of Breast Cancer in Women with False-Positive Results according to Mammographic Features. , 2016, Radiology.

[13]  C. Mathelin,et al.  [Breast imaging of mass, architectural distortion and asymmetry: Clinical practice guidelines]. , 2015, Journal de gynecologie, obstetrique et biologie de la reproduction.

[14]  J. Baker,et al.  Architectural Distortion on Mammography: Correlation With Pathologic Outcomes and Predictors of Malignancy. , 2015, AJR. American journal of roentgenology.

[15]  X. Castells,et al.  Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program , 2015, Breast Cancer Research and Treatment.

[16]  G. Colditz,et al.  Breast cancer risk associated with benign breast disease: systematic review and meta-analysis , 2015, Breast Cancer Research and Treatment.

[17]  X. Castells,et al.  Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program , 2014, Breast Cancer Research and Treatment.

[18]  C. D'Orsi.  Imaging for the diagnosis and management of ductal carcinoma in situ. , 2010, Journal of the National Cancer Institute. Monographs.

[19]  Sarah Vinnicombe,et al.  Full-field digital versus screen-film mammography: comparison within the UK breast screening program and systematic review of published data. , 2009, Radiology.

[20]  K. Kerlikowske,et al.  Positive predictive value of specific mammographic findings according to reader and patient variables. , 2009, Radiology.

[21]  V Shane Pankratz,et al.  Benign breast disease and the risk of breast cancer. , 2005, The New England journal of medicine.

[22]  W. P. Evans,et al.  Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. , 2001, Radiology.

[23]  K. Peairs,et al.  Screening for breast cancer. , 1991, Seminars in oncology.

[24]  W. Odling-Smee,et al.  Screening for Breast Cancer , 1985, The Lancet.

[25]  W D Dupont,et al.  Risk factors for breast cancer in women with proliferative breast disease. , 1985, The New England journal of medicine.

[26]  S. Heywang-Köbrunner,et al.  Clinical performance of Siemens digital breast tomosynthesis versus standard supplementary mammography for the assessment of screen-detected soft-tissue abnormalities: a multi-reader study. , 2017, Clinical radiology.

[27]  G. Baird,et al.  Comparison of digital mammography and digital breast tomosynthesis in the detection of architectural distortion , 2017, European Radiology.

[28]  L. Hartmann,et al.  Atypical hyperplasia of the breast--risk assessment and management options. , 2015, The New England journal of medicine.

[29]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .